TURN THERAPEUTICS INC

TTRXNASDAQ

🏆 #3048 by market capUS Equity

$10.51▲ $0.17 (+1.64%)

Live

1h▼ 1.2%

24h▲ 1.6%

7d▲ 11.6%

14d▲ 40.3%

30d▲ 10.3%

1y—

🏦Market Cap

$313M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

Weak

Trading Snapshot

Day Range: $10.36 – $10.59
52-Week Range: $2.57 – $26.50
Volume: $5.02B
Avg Volume: $4.09B
Shares Outstanding: 29.8M
Next Earnings: Oct 17, 2026

Fundamentals Snapshot

Annual Revenue: $24M
Last Q Revenue: $5M
P/E Ratio: —
P/S Ratio: —
EPS (TTM): $-0.13
Dividend Yield: —

Why Investors Own TTRX

✓High-growth profile — revenue up -9.5% YoY with expanding US Equity exposure.
✓Healthy economics — 70% gross margin and 16% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$24M▼ −11.9% YoY

Gross Margin (TTM)

70.0%▼ −0.4% YoY

Operating Income (TTM)

$2M▼ −11.9% YoY

Free Cash Flow (TTM)

$4M▼ −11.9% YoY

About TURN THERAPEUTICS INC

Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.

🦦